BRIEF published on 06/13/2024 at 01:05, 5 months 8 days ago Perk Labs annonce des placements privés sans intermédiaire Débentures Convertibles Laboratoires D'avantages Placements Sans Courtier Unités De Placement Privé
PRESS RELEASE published on 06/13/2024 at 01:00, 5 months 8 days ago Perk Labs Announces Non-Brokered Private Placements Perk Labs Inc. announces new non-brokered private placements of units and convertible debentures for total proceeds of $2,500,000. Closing expected on or before June 29, 2024. Finders fee may apply Perk Labs Inc. Private Placements Convertible Debentures Finders Fee Closing
BRIEF published on 05/29/2024 at 23:50, 5 months 22 days ago Perk Labs Inc. Mises à jour sur le statut MCTO MCTO BCSC États Financiers Laboratoires D'avantages Retard D'audit
BRIEF published on 05/29/2024 at 23:50, 5 months 22 days ago Perk Labs Inc. Updates on MCTO Status Financial Statements MCTO BCSC Perk Labs Audit Delay
PRESS RELEASE published on 05/29/2024 at 23:45, 5 months 22 days ago Perk Labs Inc. Provides Update on Status of MCTO Perk Labs Inc. provides an update on the management cease trade order (MCTO) by the BCSC due to delays in financial filings, with no impact on other shareholders' ability to trade Shareholders Perk Labs Inc. Management Cease Trade Order BCSC Financial Filings
BRIEF published on 05/07/2024 at 23:50, 6 months 13 days ago Perk Labs Inc. fournit une mise à jour sur l'état de l'ordonnance d'interdiction d'opérations par la direction Perk Labs Inc. MCTO Rapport Financier Réglementation Des Valeurs Mobilières NP 12-203
BRIEF published on 05/07/2024 at 23:50, 6 months 13 days ago Perk Labs Inc. Provides Update on Status of Management Cease Trade Order Perk Labs Inc. MCTO Financial Reporting Securities Regulation NP 12-203
PRESS RELEASE published on 05/07/2024 at 23:45, 6 months 13 days ago Perk Labs Inc. Provides Update on Status of MCTO Perk Labs Inc. provides update on management cease trade order application granted by the British Columbia Securities Commission, aiming to file annual financial statements by May 31, 2024 Perk Labs Inc. Management Cease Trade Order Annual Financial Statements British Columbia Securities Commission NP 12-203
BRIEF published on 04/26/2024 at 01:55, 6 months 25 days ago Perk Labs Inc. Completes Non-Brokered Private Placements Private Placement Convertible Debentures Stock Market Financial Strategy Perk Labs
BRIEF published on 04/26/2024 at 01:55, 6 months 25 days ago Perk Labs Inc. réalise des placements privés sans intermédiaire Placement Privé Stratégie Financière Bourse Débentures Convertibles Laboratoires D'avantages
Published on 11/21/2024 at 13:00, 14 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 14 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 14 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 14 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 14 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 39 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 59 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 44 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 16 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 16 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 16 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 7 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 54 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
